Recruiting Liver Disease Studies in Peoria
LIVERAGEâ„¢ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
This study is open to adults who are at least 18 years old and have: * A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or * A confirmed liver disease called metabolic-associated...
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH....
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Plac...
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
Researchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatitis (MASH). MASH was formerly called non-alcoholic s...
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis...
About Liver Disease Clinical Trials in Peoria
Chronic liver disease encompasses conditions that damage the liver over time, including cirrhosis, hepatitis, and fatty liver disease. The liver plays a crucial role in digestion, metabolism, and detoxification. Treatment depends on the cause and may include medications, lifestyle changes, or liver transplant.
There are currently 5 liver disease clinical trials recruiting participants in Peoria, ARIZONA. These studies are seeking a combined 2,962 participants. Research is being sponsored by Boehringer Ingelheim, Akero Therapeutics, Inc, Altimmune, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Liver Disease Clinical Trials in Peoria — FAQ
Are there liver disease clinical trials in Peoria?
Yes, there are 5 liver disease clinical trials currently recruiting in Peoria, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Peoria?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Peoria research site will contact you about next steps.
Are clinical trials in Peoria free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Peoria studies also compensate for your time and travel.
What liver disease treatments are being tested?
The 5 active trials in Peoria are testing new therapies including novel drugs, biologics, and treatment approaches for liver disease.
Data updated March 2, 2026 from ClinicalTrials.gov